46,XX Testicular Disorders of Sex Development With DMD Gene Mutation: First Case Report Identified Prenatally by Integrated Analyses in China

The present study describes the first prenatally diagnosed 46,XX testicular disorders of sex development (46,XX testicular DSD) case with DMD gene mutation by integrated analyses in a Chinese pedigree. Chromosome karyotype G-banding analysis of the proband showed a 46,XX karyotype, but B-ultrasound analysis demonstrated the existence of scrotum, testis and penis which inferred a male sexual differentiation. Aneuploidy and copy number variation (CNV) detection by low-coverage single-end whole genome sequencing (WGS) revealed a de novo SRY (sex-determining region Y) gene positive fragment of 224.34 kb length (chrY:2,649,472-2,873,810) which explained the gonadal/genital-chromosomal inconsistency in the proband. Additionally, targeted-region-capture-based DMD gene sequencing and Sanger verification confirmed a widely reported pathogenic heterozygous nonsense mutation (NM_004006, c.9100C>T, p.Arg3034Ter) in the dystrophin-coding gene named DMD. This study emphasizes that integrated analyses of the imaging results, cytogenetics, and molecular features can play an important role in prenatal diagnosis. It requires the combination of more detection techniques with higher resolution than karyotyping to determine the genetic and biological sex of fetuses in prenatal diagnosis. To conclusively determine both the biological and genetic sex of the fetus at the time of prenatal diagnosis particularly in cases that involve X-linked conditions is of vital importance, which would crucially influence the decision-making regarding abortions. This study will help in prenatal diagnosis of DMD in future, also providing a new perspective that enables the genetic diagnosis of sex reversal in pregnancy. Moreover, genetic counseling/analysis for early diagnosis and pre-symptom interventions are warranted.

[1]  A. Sinclair,et al.  Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9 , 2018, Nature Communications.

[2]  K. Main,et al.  Incidence, prevalence, diagnostic delay, morbidity, mortality and socioeconomic status in males with 46,XX disorders of sex development: a nationwide study , 2017, Human reproduction.

[3]  Wen-ting Jiang,et al.  Prenatal diagnosis of Duchenne muscular dystrophy in 131 Chinese families with dystrophinopathy , 2017, Prenatal diagnosis.

[4]  E. Viggiano,et al.  Skewed X‐chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy , 2017, The journal of gene medicine.

[5]  Z. Papp,et al.  Ethical issues in genetic counseling. , 2017, Best practice & research. Clinical obstetrics & gynaecology.

[6]  R. Rey,et al.  Disorders of Sex Development with Testicular Differentiation in SRY-Negative 46,XX Individuals: Clinical and Genetic Aspects , 2016, Sexual Development.

[7]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[8]  Y. Cui,et al.  Clinical, molecular and cytogenetic analysis of 46, XX testicular disorder of sex development with SRY-positive , 2014, BMC Urology.

[9]  Xun Xu,et al.  A Robust Approach for Blind Detection of Balanced Chromosomal Rearrangements with Whole‐Genome Low‐Coverage Sequencing , 2014, Human mutation.

[10]  Xiuqing Zhang,et al.  PSCC: Sensitive and Reliable Population-Scale Copy Number Variation Detection Method Based on Low Coverage Sequencing , 2014, PloS one.

[11]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[12]  A. Abacı,et al.  46,XX Male Disorder of Sexual Development: A Case Report , 2013, Journal of clinical research in pediatric endocrinology.

[13]  Hutton M. Kearney,et al.  ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013 , 2013, Genetics in Medicine.

[14]  E. Vilain,et al.  Translational genetics for diagnosis of human disorders of sex development. , 2013, Annual review of genomics and human genetics.

[15]  Ping Liu,et al.  A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing , 2013, Prenatal diagnosis.

[16]  Xiuqing Zhang,et al.  Rapid detection of aneuploidies on a benchtop sequencing platform , 2013, Prenatal diagnosis.

[17]  T. Ozcelik,et al.  Two Males with SRY-Positive 46,XX Testicular Disorder of Sex Development , 2013, Systems biology in reproductive medicine.

[18]  R. Finkel,et al.  MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy , 2012, Neuromuscular Disorders.

[19]  Hui Jiang,et al.  Prenatal Detection of Aneuploidy and Imbalanced Chromosomal Arrangements by Massively Parallel Sequencing , 2012, PloS one.

[20]  S. South,et al.  American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants , 2011, Genetics in Medicine.

[21]  N. Bresolin,et al.  Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing , 2011, BMC Medical Genetics.

[22]  B. Zinman,et al.  HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study , 2011, BMC Medical Genetics.

[23]  R. Finkel,et al.  Clinical and genetic characterization of manifesting carriers of DMD mutations , 2010, Neuromuscular Disorders.

[24]  Livija Medne,et al.  Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort , 2009, Human mutation.

[25]  S. Pandya,et al.  Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007. , 2009, MMWR. Morbidity and mortality weekly report.

[26]  J. Chen,et al.  46, XX male sex reversal syndrome: a case report and review of the genetic basis , 2009, Andrologia.

[27]  Han N. Lim,et al.  Mutation analysis of subjects with 46, XX sex reversal and 46, XY gonadal dysgenesis does not support the involvement of SOX3 in testis determination , 2000, Human Genetics.

[28]  T. Frieden,et al.  Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007. , 2009, MMWR. Morbidity and mortality weekly report.

[29]  A. Rizvi 46, XX Man with SRY Gene Translocation: Cytogenetic Characteristics, Clinical Features and Management , 2008, The American journal of the medical sciences.

[30]  Peter A. Lee,et al.  Disorders of sex development , 2007, Current opinion in obstetrics & gynecology.

[31]  B. Migeon Why females are mosaics, X-chromosome inactivation, and sex differences in disease. , 2007, Gender medicine.

[32]  S. Ahmed,et al.  Consensus Statement on Management of Intersex Disorders , 2006, Pediatrics.

[33]  P. A. Lee,et al.  Consensus statement on management of intersex disorders , 2006, Archives of Disease in Childhood.

[34]  K. McElreavey,et al.  Clinical, Hormonal and Cytogenetic Evaluation of 46,XX Males and Review of the Literature , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[35]  Thomas W Prior,et al.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy. , 2005, The Journal of molecular diagnostics : JMD.

[36]  J. T. Dunnen,et al.  Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort , 2005, American journal of medical genetics. Part A.

[37]  G. Berkovitz,et al.  46,XX sex reversal with partial duplication of chromosome arm 22q , 2004, American journal of medical genetics. Part A.

[38]  P. Jacobs,et al.  Familial X/Y translocations associated with variable sexual phenotype , 2004, Journal of Medical Genetics.

[39]  Han N. Lim,et al.  Mutation analysis of subjects with 46, XX sex reversal and 46, XY gonadal dysgenesis does not support the involvement of SOX3 in testis determination , 2004, Human Genetics.

[40]  A. Chapelle The etiology of maleness in XX men , 2004, Human Genetics.

[41]  F. Rivasi,et al.  Early prenatal diagnosis of recurrent 46,XY partial gonadal dysgenesis , 2003, Prenatal diagnosis.

[42]  L. Gavrilă,et al.  Scrreening for microdeletions in human Y chromosome‐AZF candidate genes and male infertility , 2003 .

[43]  A. Saâd,et al.  Skewed X-chromosome inactivation pattern in SRY positive XX maleness: a case report and review of literature. , 2003, Annales de genetique.

[44]  MF Lyon X‐chromosome inactivation and human genetic disease , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[45]  K. McElreavey,et al.  X-Y translocations and sex differentiation. , 2001, Seminars in reproductive medicine.

[46]  W P Robinson,et al.  The causes and consequences of random and non‐random X chromosome inactivation in humans , 2000, Clinical genetics.

[47]  Y. Ning,et al.  Autosomal XX sex reversal caused by duplication of SOX9. , 1999, American journal of medical genetics.

[48]  A M Walker,et al.  Common Language , 1996, Pharmacoepidemiology and drug safety.

[49]  S. Wachtel,et al.  XX Sex Reversal in the Human , 1994 .

[50]  Robin Lovell-Badge,et al.  A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif , 1990, Nature.

[51]  L. Hood,et al.  A common language for physical mapping of the human genome. , 1989, Science.

[52]  I. Craig,et al.  Muscular dystrophy in girls with X;autosome translocations. , 1986, Journal of medical genetics.

[53]  A. Ossipov,et al.  Duchenne muscular dystrophy , 2004 .

[54]  M. Niemi,et al.  XX SEX CHROMOSOMES IN A HUMAN MALE. FIRST CASE. , 2009, Acta medica Scandinavica.